Brianne Dressen
speaker
46 appearances
1 recordings
1 series
first heard Nov 2024
last heard Nov 2024
Brianne Dressen’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
Thanks for having me.
Everything started at the beginning of the pandemic, just like anybody else. I was watching the news and I was really concerned about what I was seeing. I have a lot of medical professionals in my family and hearing what was going on in the hospitals was also alarming to say the least.
So I wanted to do my part to help get everybody out of the pandemic, and I enrolled in a clinical trial with AstraZeneca here in the United States. So November 4th, 2020, I got my one and only shot, and my reaction started within an hour. And I started with this severe, strange pins and needles sensation down the same arm as my injection. And it spread to my other arm, my body, head to toe.
And that same horrific pins and needles prickling sensation is with me to this day, every moment of every day. I landed in the hospital.
I actually have it body wide. So it's, yeah, it's spread from one side to the other. And then it spread from my head down to my feet and it actually moves with my heartbeat. So, and I do understand what you're saying. Yeah. So it's the first thing I feel when I wake up in the morning. It's the last thing I feel when I not off to sleep with a bunch of meds to calm down the severe pain. So yeah.
Yes. So the first time I had a nerve biopsy done, it was at the National Institutes of Health when they flew 20 plus of us out to be studied for neurological complications to the COVID vaccines. My first neuropathy test showed very minor, minuscule levels. I just had it rechecked. So three years later, and it's definitely progressing and getting worse. Okay.
So I've been diagnosed with post-vaccine neuropathy from the National Institutes of Health. That's been verified by several world experts, as well as dysautonomia, POTS, which is the heart dysregulation. It's basically a neuroimmune condition. where your immune system can't really help your nervous system regulate itself.
And it does end up in a multi-system cascade of syndromes from brain fog, fatigue, pins and needles, numbness, weakness, heart rate fluctuations, food sensitivities, hair loss. It sounds an awful lot like long COVID. Yeah.
But it's interesting because we really should be studying long COVID and post-vax syndrome or long vax so we can actually get both of the patient populations better.
I was the only patient from AstraZeneca in the trial. Everybody else was Pfizer, Moderna. There was one other person with J&J in the trial.
J&J is an adenoviral vector vaccine. So it's a very similar technology. Yeah.
Yeah, so AstraZeneca is an Oxford product. So it was the golden child in the UK. And the UK, at the very beginning of the vaccine rollout, they were telling the public, don't get the mRNA products. Just hang on for a couple more weeks. AstraZeneca is coming. This is the superior product of the UK.
And then in the US, they had the golden children, which was Pfizer and Moderna, the new novel mRNA technology.
These were all neuroimmune conditions. So they checked all of us with the similar testing. They checked the coagulation of our blood. They checked the MRIs, which just like everybody else, the MRIs looked fine. But that's when they really started looking into dysautonomia and POTS, small fiber neuropathy, EMGs with a large fiber neuropathy decay.
And that's one thing that we've learned through our own research is the significant overlap between long COVID and post-vax syndrome. They look near identical, but there is a signature. And people that are suffering with post-vaccine adverse events really do have a higher likelihood of having these longer term neurological nerve damage type syndromes.
I do. Yeah. My EMG came back positive on my left leg.
It was interesting. They couldn't quite identify it early on. And because of the political dynamic going on in the United States in the summer of 2021, they actually shut down the study in the middle of it. So they were following up with every single participant weekly saying, hey, what are your symptoms doing? We've got some more updates on these tests that we've been waiting on.
They were really engaging with the patients in a You know, in a way that you would expect the government to be doing with a new novel set of diseases, right? But then, of course, OSHA mandates happened. And literally within days, our follow-up appointments to the NIH were canceled. Even our flights were canceled to go out there again. And all of a sudden, it was radio silence. So...
Funny you ask. The FDA, we plugged in with them at the end of summer of 2021. At this time, it was Peter Marks, head of biologics at the FDA. We had several meetings with him, coordinating with him to discuss why they're not following the rest of the world in communicating these adverse events as they emerge to the American public, as we saw in Germany and Denmark earlier.
They were doing something different, right? They gave us injured people that were advocating for other injured people. They gave us a long list of things that we should be doing to help them do their jobs. They asked us for all of the terms of neuropathy that we had identified in their VAERS system. They also did acknowledge to us that small fiber neuropathy is happening after COVID vaccination.
Showing 1–20 of 46 · page 1 of 3
Next →